Cumulative effect of Levodopa in obstacle crossing: Case study of a Parkinson disease patient
DOI:
https://doi.org/10.20338/bjmb.v6i2.33Keywords:
Parkinson's disease, complex environment, Levodopa, GaitAbstract
The locomotor behavior of individuals with Parkinson’s disease (PD) is strongly affected by the Levodopa kinetics. Then, our aim was to analyze indirectly the Levodopa kinetics on the locomotor behavior during one day by means of the gait kinematic analyses during obstacle avoidance of one PD patient in advanced stage. WM, man, 72 years of age, 18 years with PD, stage IV of the disease, participated in this study. WM presented the following history: PD initiated by tremors of the right hand followed by tremors on the left hand, rigidity in the right lower limb first and on the left lower limb latter and then the cervical region; palidotomy 10 years ago decreasing the tremors. WM came into the lab for testing twice in the same day. During the afternoon, the patient presented larger improvements in his motor functions. The spatial and temporal parameters of the free walking and the obstacle avoidance revealed a cumulative effect of the motor responses to the Levodopa. This effect was observed by improvements in all variables and their variability. WM used adaptive locomotor strategies during obstacle avoidance. The Levodopa was efficient to normalize the gait pattern during the day.
Downloads
Metrics
Downloads
Published
How to Cite
Issue
Section
License
Authors must declare that the work submitted is their own and that copyright has not been breached in seeking its publication. If the manuscript includes work previously published elsewhere, it is the author(s) responsibility to obtain permission to use it and to indicate that such permission has been granted.
Authors retain the copyright of their paper and grant the Brazilian Journal of Motor Behavior (BJMB) the right to first publish the work under a Creative Commons Attribution-NonCommercial-NoDerivatives license (CC BY-NC-ND). This license allows users to share the paper given the appropriate credit to the author and source and does not allow commercial uses and derivative materials to be produced.